deucravacitinib,apremilast
amgen,bms
['ade ', 'deucrava', 'deucra', 'abion', 'bristol']
labn feed: bristol myers wins a megablockuster bet with tyk2 fda approval and there's a big bonus for the label: bristol myers squibb made a megablockbuster bet on deucravacitinib, the ... #losangeles #biotech 
Los Angeles and Orange County #California #biotech news and events, for jobs follow @labnjobs #losangeles #orangecounty #lifescience